IRIS
ANELLI, MARIA GRAZIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.091
AS - Asia 1.074
EU - Europa 943
SA - Sud America 273
AF - Africa 40
OC - Oceania 2
Totale 5.423
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.041
SG - Singapore 476
CN - Cina 237
BR - Brasile 219
DE - Germania 198
SE - Svezia 169
RU - Federazione Russa 144
HK - Hong Kong 114
FR - Francia 97
IT - Italia 88
VN - Vietnam 83
GB - Regno Unito 75
FI - Finlandia 73
BE - Belgio 31
IN - India 31
AR - Argentina 25
CA - Canada 20
MX - Messico 19
BD - Bangladesh 18
UA - Ucraina 17
IQ - Iraq 14
PK - Pakistan 13
TR - Turchia 13
ZA - Sudafrica 13
CI - Costa d'Avorio 12
ID - Indonesia 12
IR - Iran 10
JP - Giappone 10
CO - Colombia 8
PL - Polonia 8
CZ - Repubblica Ceca 7
SA - Arabia Saudita 7
UZ - Uzbekistan 7
AT - Austria 6
CL - Cile 6
ES - Italia 6
EC - Ecuador 5
MA - Marocco 5
NL - Olanda 5
PH - Filippine 5
PY - Paraguay 5
CR - Costa Rica 4
MY - Malesia 4
AZ - Azerbaigian 3
DO - Repubblica Dominicana 3
LT - Lituania 3
NP - Nepal 3
EG - Egitto 2
HU - Ungheria 2
IE - Irlanda 2
IL - Israele 2
KZ - Kazakistan 2
OM - Oman 2
PE - Perù 2
RO - Romania 2
VE - Venezuela 2
AL - Albania 1
AM - Armenia 1
AU - Australia 1
BB - Barbados 1
BG - Bulgaria 1
BW - Botswana 1
CH - Svizzera 1
DZ - Algeria 1
ET - Etiopia 1
GE - Georgia 1
GF - Guiana Francese 1
HR - Croazia 1
IS - Islanda 1
JM - Giamaica 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MD - Moldavia 1
MM - Myanmar 1
MN - Mongolia 1
MP - Marianne Settentrionali, isole 1
MT - Malta 1
MW - Malawi 1
NG - Nigeria 1
PA - Panama 1
RS - Serbia 1
SD - Sudan 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TL - Timor Orientale 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
ZW - Zimbabwe 1
Totale 5.423
Salva come PNG Salva come JPEG
Città #
Ashburn 336
Fairfield 315
Chandler 286
Singapore 275
Woodbridge 257
Houston 166
Seattle 166
Ann Arbor 150
San Jose 146
Nyköping 141
Cambridge 119
Hong Kong 112
Beijing 107
Wilmington 102
Munich 57
Dallas 56
New York 53
Jacksonville 46
Los Angeles 44
Lawrence 39
Roxbury 39
Lauterbourg 33
Moscow 33
Brussels 31
Bari 30
Helsinki 29
Des Moines 27
Turku 27
Dearborn 26
Ho Chi Minh City 26
Inglewood 26
Brooklyn 25
Nanjing 24
San Diego 20
Buffalo 19
London 18
Santa Clara 18
Paris 17
São Paulo 15
Hanoi 13
Princeton 13
Abidjan 12
San Francisco 12
Frankfurt am Main 10
Orem 10
Poplar 10
Tokyo 10
Redwood City 9
Belo Horizonte 8
Boardman 8
Denver 8
Hebei 8
Brasília 7
Chicago 7
Dong Ket 7
Jakarta 7
Johannesburg 7
Lahore 7
Montreal 7
Mumbai 7
Shanghai 7
Toronto 7
Warsaw 7
Boston 6
Council Bluffs 6
Milan 6
Nanchang 6
Tashkent 6
Ardabil 5
Falkenstein 5
Haiphong 5
Mexico City 5
Nuremberg 5
Vienna 5
Amsterdam 4
Atlanta 4
Changsha 4
Chennai 4
Da Nang 4
Guangzhou 4
Hefei 4
Jinan 4
Kunming 4
Ottawa 4
Querétaro 4
Quito 4
Rio de Janeiro 4
Shenyang 4
Tianjin 4
Washington 4
Augusta 3
Baghdad 3
Baku 3
Bauru 3
Benito Juarez 3
Buenos Aires 3
Cape Town 3
Curitiba 3
Detroit 3
Goiânia 3
Totale 3.818
Salva come PNG Salva come JPEG
Nome #
Sarcopenia in Patients with Rheumatic Diseases: Prevalence and Associated Risk Factors 201
AB0836 Drug retention rate of the first tnf inhibitor in radiographic and non radiographic axial spondyloarthritis: data from a multicenter study 187
AB0065 Possible Interplay Between Serum Amyloid-A and Pro-Inflammatory Cytokines Into the Pathogenesis of Behçet's Disease 183
AB0452 Changes in Lipoproteins Associated with Tocilizumab Treatment Do not Influence the Atherogenic Index of Plasma of Rheumatoid Arthritis Patients: Table 1 175
AB0618 A unique ultrasound pattern of adipose tissue in systemic sclerosis patients: a comparison with rheumatoid arthritis patients and healthy controls. two sides of adipose tissue involvement in systemic chronic inflammatory diseases 172
Early changes of articular cartilage, synovial membrane and subchondral bone in an experimental model of goat osteoarthrtitis 167
Obesity reduces the drug survival of second line biological drugs following a first TNF-α inhibitor in rheumatoid arthritis patients 165
AB0041 Serum Amyloid A Stimulates The Induction of Inflammatory Mediators in Monocytes from Behçet's Disease Patients: A Proof of Concept Study 164
Two-year survival rates of anti-TNF-α therapy in psoriatic arthritis (PsA) patients with either polyarticular or oligoarticular PsA 161
Interleukin-1 as a common denominator from autoinflammatory to autoimmune disorders: Premises, perils, and perspectives 161
Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: Results from the GISEA register 160
SAT0216 Chest Ultrasound Signs of Interstitial Lung Disease in Systemic Sclerosis Patients: A Comparison between High Resolution Chest Computed Tomography Findings 153
Body mass does not affect the remission of psoriatic arthritis patients on anti-TNF-α therapy 152
Lipids and atherogenic indices fluctuation in rheumatoid arthritis patients on long-term tocilizumab treatment 152
Golimumab in real-life settings: 2 Years drug survival and predictors of clinical outcomes in rheumatoid arthritis, spondyloarthritis, and psoriatic arthritis 151
Lipid Profile of Rheumatoid Arthritis Patients Treated with Anti-Tumor Necrosis Factor-Alpha Drugs Changes According to Disease Activity and Predicts Clinical Response 148
Effectiveness and tuberculosis-related safety profile of interleukin-1 blocking agents in the management of Behçet's disease 146
Old and new antirheumatic drugs and the risk of hepatotoxicity 146
THU0153 The effect of 5-years b-dmards treatment on different 10-years cardiovascular risk scores applied in rheumatoid arthritispatients 142
SAT0212 Pericardial Effusion Related To Systemic Sclerosis: A Possible Contribution of The Serum Levels of Adipokines and Interleukines 137
LIPID PROFILE OF RHEUMATOID ARTHRITIS PATIENTS TREATED WITH ANTI-TNF-ALPHA DRUGS CHANGES ACCORDING TO DISEASE ACTIVITY RESPONSE 136
FRI0110 Methotrexate monotherapy in real life: a drug survival analysis. comparison between very early arthritis and early arthritis cohorts 134
Improvement of renal function and disappearance of hepatitis B virus DNA in a patient with rheumatoid arthritis and renal amyloidosis following treatment with infliximab 129
Management of Small Vessel Vasculitides 128
Evaluation of Serum Levels of Adipokines and Interleukines in Pericardial Effusion Related to Systemic Sclerosis 127
OP0129 Drug survival on anti-tnf-alpha in psoriatic arthritis patients with axial involvement and analysis of predictors 124
The Impact of Biologic Drugs on High-Density Lipoprotein Cholesterol Efflux Capacity in Rheumatoid Arthritis Patients 119
Giant Cell Tumor of Synovial Sheath: Of Two Cases Treated with Intra-Articular Infiltration of Infliximab 114
THU0168 Relationships between body fat composition assessed with bioelectrical impedance analysis, serum adipokines and disease activity in patients with rheumatoid arthritis 114
Intentional etanercept use during pregnancy for maintenance of remission in rheumatoid arthritis 113
SAT0380 FIBROMYALGIA IS THE STRONGEST NEGATIVE PREDICTOR FOR THE ACHIEVEMENT OF EITHER REMISSION AND MINIMAL DISEASE ACTIVITY IN NAIVE PSORIATIC ARTHRITIS PATIENTS STARTING BIOLOGIC DRUGS 108
EARLY CHANGES OF ARTHICULAR CARTILAGE, SYNOVIAL MEMBRANE AND SUBCHONDRAL BONE IN AN EXPERIMENTAL MODEL OF GOAT OSTEOARTHRITIS 106
OPG-RANKL system and Osteopontin in a postmenopausal women population. ANNALS OF THE RHEUMATIC DISEASES 102
null 101
null 97
High disease relapse after bDMARD spacing in psoriatic arthritis compared to rheumatoid arthritis and axial spondyloarthritis patients: real-life data from BIOPURE registry 97
Long-term safety of anti-TNF agents on the liver of patients with spondyloarthritis and potential occult hepatitis B viral infection: an observational multicentre study 92
Temporomandibular Disorders and Oral Features in Early Rheumatoid Arthritis Patients: An Observational study. 86
Tomographic regression of pulmonary rheumatoid nodules under baricitinib therapy 78
La qualità di vita nelle poliartriti croniche. Studio preliminare 65
Influence of TNF- α inhibition on oxidative stress of rheumatoid arthritis patients 63
L'obésité diminue le maintien thérapeutique des traitements biologiques de seconde ligne après échec d'un anti-TNF de première ligne au cours de la polyarthrite rhumatoïde 62
Disease activity assessment for juvenile idiopathic arthritis in transitional care 21
Turning the Tide against Herpes Zoster in Rheumatoid Arthritis Patients Treated with JAK Inhibitors 14
Totale 5.553
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.815
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.815
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021132 0 0 0 0 0 0 0 0 0 56 44 32
2021/2022362 20 24 8 13 18 31 10 19 19 30 57 113
2022/2023659 72 106 46 66 71 83 16 78 88 5 17 11
2023/2024154 8 35 10 17 15 41 2 5 0 3 2 16
2024/2025870 18 16 63 25 13 74 91 107 41 51 135 236
2025/20261.609 276 88 104 192 275 104 174 47 188 161 0 0
Totale 5.553